chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Erythema, Peripheral swelling
Clinical narrative: chills; redness; swelling; burning sensation; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), ERYTHEMA (redness), PERIPHERAL SWELLING (swelling) and BURNING SENSATION (burning sensation) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M204 and 012A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ALLOPURINOL, PRAVASTATIN, PARACETAMOL (TYLENOL) and PREDNISONE for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced CHILLS (chills), ERYTHEMA (redness), PERIPHERAL SWELLING (swelling) and BURNING SENSATION (burning sensation). At the time of the report, CHILLS (chills), ERYTHEMA (redness), PERIPHERAL SWELLING (swelling) and BURNING SENSATION (burning sensation) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter.  Upon internal review on 04-AUG-2021, the age was corrected to 80 years and gender corrected as being a male patient.    Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Patient details were updated.First dose and second dose details were updated.events were updated.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: achy arm; tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (achy arm) and FATIGUE (tired) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced VACCINATION SITE PAIN (achy arm) and FATIGUE (tired). At the time of the report, VACCINATION SITE PAIN (achy arm) and FATIGUE (tired) had resolved. Not Provided          No treatment medications were reported. No concomitant medications were reported. Patient declined for further follow-up and declined consent to speak to her HCP for events.   This case was linked to MOD21-073300 (E2B Linked Report). This case was linked to MOD21-073300 (Patient Link).; Sender's Comments:  MOD21-073300:Link to Dose 1 MOD-2021-073116
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Cluster headache, Dizziness, Inappropriate schedule of product administration, Insomnia
Clinical narrative: Bad headaches for 5 weeks; 4 weeks of Vertigo; Dizzy; Off balance spells/Spent 4 weeks lying down most of the time; Migraines; Sore arm; Pain so bad she can't go to sleep; 79-day gap of both doses; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), INSOMNIA (Pain so bad she can't go to sleep), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (79-day gap of both doses), CLUSTER HEADACHE (Bad headaches for 5 weeks) and VERTIGO (4 weeks of Vertigo) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 00621A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine, Kidney disorder and Allergy to plants (trees and shrubs). Concomitant products included ELETRIPTAN HYDROBROMIDE (RELPAX) for Migraine, LEVOTHYROXINE for Thyroid disorder, ESTROGENS CONJUGATED (PREMARIN) for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), INSOMNIA (Pain so bad she can't go to sleep) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (79-day gap of both doses). On an unknown date, the patient experienced CLUSTER HEADACHE (Bad headaches for 5 weeks), VERTIGO (4 weeks of Vertigo), DIZZINESS (Dizzy), BALANCE DISORDER (Off balance spells/Spent 4 weeks lying down most of the time) and MIGRAINE (Migraines). On 23-Feb-2021, INSOMNIA (Pain so bad she can't go to sleep) had resolved. On 07-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (79-day gap of both doses) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved and CLUSTER HEADACHE (Bad headaches for 5 weeks), VERTIGO (4 weeks of Vertigo), DIZZINESS (Dizzy), BALANCE DISORDER (Off balance spells/Spent 4 weeks lying down most of the time) and MIGRAINE (Migraines) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No treatment included extra doses of Relpax.     Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: FOLLOW UP RECEIVED NO NEW INFORMATION WAS FOUND.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pain in extremity, Vertigo
Clinical narrative: Bad headaches for 5 weeks; 4 weeks of Vertigo; Dizzy; Off balance spells/Spent 4 weeks lying down most of the time; Migraines; Sore arm; Pain so bad she can't go to sleep; 79-day gap of both doses; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), INSOMNIA (Pain so bad she can't go to sleep), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (79-day gap of both doses), CLUSTER HEADACHE (Bad headaches for 5 weeks) and VERTIGO (4 weeks of Vertigo) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 00621A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine, Kidney disorder and Allergy to plants (trees and shrubs). Concomitant products included ELETRIPTAN HYDROBROMIDE (RELPAX) for Migraine, LEVOTHYROXINE for Thyroid disorder, ESTROGENS CONJUGATED (PREMARIN) for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), INSOMNIA (Pain so bad she can't go to sleep) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (79-day gap of both doses). On an unknown date, the patient experienced CLUSTER HEADACHE (Bad headaches for 5 weeks), VERTIGO (4 weeks of Vertigo), DIZZINESS (Dizzy), BALANCE DISORDER (Off balance spells/Spent 4 weeks lying down most of the time) and MIGRAINE (Migraines). On 23-Feb-2021, INSOMNIA (Pain so bad she can't go to sleep) had resolved. On 07-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (79-day gap of both doses) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved and CLUSTER HEADACHE (Bad headaches for 5 weeks), VERTIGO (4 weeks of Vertigo), DIZZINESS (Dizzy), BALANCE DISORDER (Off balance spells/Spent 4 weeks lying down most of the time) and MIGRAINE (Migraines) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No treatment included extra doses of Relpax.     Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: FOLLOW UP RECEIVED NO NEW INFORMATION WAS FOUND.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, Antibody test abnormal
Clinical narrative: antibody test came back at 0.4 and she was told it should be at 0.8 or higher(received results on 11/May/2021).; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST ABNORMAL (antibody test came back at 0.4 and she was told it should be at 0.8 or higher(received results on 11/May/2021).) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 002C21A) for COVID-19 vaccination.     Concurrent medical conditions included Lupus syndrome. Concomitant products included HYDROXYCHLOROQUINE SULFATE (PLAQUENIL S), MYCOPHENOLATE MOFETIL (CELLCEPT [MYCOPHENOLATE MOFETIL]), VITAMIN D NOS and PREDNISONE for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced ANTIBODY TEST ABNORMAL (antibody test came back at 0.4 and she was told it should be at 0.8 or higher(received results on 11/May/2021).). At the time of the report, ANTIBODY TEST ABNORMAL (antibody test came back at 0.4 and she was told it should be at 0.8 or higher(received results on 11/May/2021).) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-May-2021, Antibody test: 0.4 (abnormal) Result should be 0.8 or higher..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.  Patient was using 12 other unspecified concomitant medications.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: Nurse stated that she had 3 patients who received 1ml of 1st dose of moderna covid-19 vaccine instead of receiving 0.5ml; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (Nurse stated that she had 3 patients who received 1ml of 1st dose of moderna covid-19 vaccine instead of receiving 0.5ml) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (Nurse stated that she had 3 patients who received 1ml of 1st dose of moderna covid-19 vaccine instead of receiving 0.5ml). At the time of the report, ACCIDENTAL OVERDOSE (Nurse stated that she had 3 patients who received 1ml of 1st dose of moderna covid-19 vaccine instead of receiving 0.5ml) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   No treatment information was provided.  Nurse stated that she had 3 patients who received 1ml of 1st dose of Moderna COVID-19 vaccine instead of receiving 0.5ml. So, she was looking for the guidance for double dose error and wanted to know about any recommendations on how to proceed with the 2nd dose.   No adverse event occurred post vaccination. VAERS submitted to CDC. All 3 vaccine recipients refused 2nd doses.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: No adverse event occurred post vaccination.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Costochondritis, Gastrooesophageal reflux disease, Headache, Product dose omission issue
Clinical narrative: Rib cage Pain/Costochondritis; acid reflux disease; Doctor advised patient not to take the second dose which was due on 6th April; Slight headache 4 days after Covid-19 injection administration; This spontaneous case was reported by a consumer and describes the occurrence of COSTOCHONDRITIS (Rib cage Pain/Costochondritis), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux disease), PRODUCT DOSE OMISSION ISSUE (Doctor advised patient not to take the second dose which was due on 6th April) and HEADACHE (Slight headache 4 days after Covid-19 injection administration) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. not provided) for COVID-19 vaccination.     The patient's past medical history included Depression. Concomitant products included PARACETAMOL (TYLENOL).    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced HEADACHE (Slight headache 4 days after Covid-19 injection administration). On an unknown date, the patient experienced COSTOCHONDRITIS (Rib cage Pain/Costochondritis), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux disease) and PRODUCT DOSE OMISSION ISSUE (Doctor advised patient not to take the second dose which was due on 6th April). At the time of the report, COSTOCHONDRITIS (Rib cage Pain/Costochondritis), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux disease), PRODUCT DOSE OMISSION ISSUE (Doctor advised patient not to take the second dose which was due on 6th April) and HEADACHE (Slight headache 4 days after Covid-19 injection administration) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Myalgia
Clinical narrative: didn't feel good; tired; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (didn't feel good), FATIGUE (tired) and MYALGIA (arm was sore) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (didn't feel good), FATIGUE (tired) and MYALGIA (arm was sore). At the time of the report, FEELING ABNORMAL (didn't feel good), FATIGUE (tired) and MYALGIA (arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment medications were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-123397, US-MODERNATX, INC.-MOD-2021-123340 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-123397:crosslinked US-MODERNATX, INC.-MOD-2021-123340:crosslinked
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered to 20 individuals; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 20 individuals) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 20 individuals). On 07-May-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 20 individuals) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Twenty individuals received the dose one day out of expiration (31 days in the refrigerated condition). No symptoms were reported from the patients as of 12-MAY-2021. Treatment information was not provided.
Age: 74.0
Sex: U
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: at least half of the dose was noted to have leaked out; Vaccine leaked down patient's arm; This spontaneous case was reported by a physician and describes the occurrence of UNDERDOSE (at least half of the dose was noted to have leaked out) and DEVICE CONNECTION ISSUE (Vaccine leaked down patient's arm) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced UNDERDOSE (at least half of the dose was noted to have leaked out) and DEVICE CONNECTION ISSUE (Vaccine leaked down patient's arm). At the time of the report, UNDERDOSE (at least half of the dose was noted to have leaked out) and DEVICE CONNECTION ISSUE (Vaccine leaked down patient's arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Call transferred by Moderna customer care representative with case number 00164162. Physician called to report that a staff member at their clinic reported today (12May2021) that while administering the second dose (lot number 037B21A) of the Moderna Covid 19 vaccine on 30Apr2021 to a patient (Name not provided), some of the vaccine leaked out and ran down their arm. Staff member confirmed that at least half of the dose was noted to have leaked out. Physician wouldn't share patient information other than the lot number, agent shared the case for physician to share with the patient to call back with contact information. Physician wanted to know is the patient should be re-vaccinated and if they are they still within the window to receive the second dose if needed. Physician gave consent for the safety team to follow-up and prefers email for future communication.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: This spontaneous case reported by a patient, describes the occurrence of nausea, vomiting and pyrexia (fever) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On May 12, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On May 13, 2021, patient experienced nausea, vomiting and pyrexia (fever). At the time of the report, nausea, vomiting and pyrexia (fever) outcome: unknown. No concomitant medications or treatment information provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Feeling hot, Malaise, Myalgia
Clinical narrative: face is warm/ hot to touch / feft arm was hot to touch; still see the mark where the needle went in; red / redness is 3-4 inches wide/ redness is 2 inches down from where the shot was given; I am freezing; pain under my arm/ pain in left arm; left arm swollen / whole upper arm is swollen; hard to sleep; not good; everyday chills; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (left arm swollen / whole upper arm is swollen), NASOPHARYNGITIS (I am freezing), SLEEP DISORDER (hard to sleep), FEELING HOT (face is warm/ hot to touch / feft arm was hot to touch) and VACCINATION SITE DISCOLOURATION (still see the mark where the needle went in) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included INTERFERON BETA-1A (AVONEX) for Multiple sclerosis.    On 04-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced PERIPHERAL SWELLING (left arm swollen / whole upper arm is swollen), SLEEP DISORDER (hard to sleep), MALAISE (not good) and CHILLS (everyday chills). On 12-May-2021, the patient experienced NASOPHARYNGITIS (I am freezing), FEELING HOT (face is warm/ hot to touch / feft arm was hot to touch), VACCINATION SITE DISCOLOURATION (still see the mark where the needle went in), ERYTHEMA (red / redness is 3-4 inches wide/ redness is 2 inches down from where the shot was given) and MYALGIA (pain under my arm/ pain in left arm). The patient was treated with PARACETAMOL (TYLENOL) on 04-May-2021 at a dose of 500mg. At the time of the report, PERIPHERAL SWELLING (left arm swollen / whole upper arm is swollen), NASOPHARYNGITIS (I am freezing), SLEEP DISORDER (hard to sleep), FEELING HOT (face is warm/ hot to touch / feft arm was hot to touch), VACCINATION SITE DISCOLOURATION (still see the mark where the needle went in), ERYTHEMA (red / redness is 3-4 inches wide/ redness is 2 inches down from where the shot was given), MALAISE (not good), CHILLS (everyday chills) and MYALGIA (pain under my arm/ pain in left arm) had not resolved.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Peripheral swelling, Sleep disorder, Vaccination site discolouration
Clinical narrative: face is warm/ hot to touch / feft arm was hot to touch; still see the mark where the needle went in; red / redness is 3-4 inches wide/ redness is 2 inches down from where the shot was given; I am freezing; pain under my arm/ pain in left arm; left arm swollen / whole upper arm is swollen; hard to sleep; not good; everyday chills; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (left arm swollen / whole upper arm is swollen), NASOPHARYNGITIS (I am freezing), SLEEP DISORDER (hard to sleep), FEELING HOT (face is warm/ hot to touch / feft arm was hot to touch) and VACCINATION SITE DISCOLOURATION (still see the mark where the needle went in) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included INTERFERON BETA-1A (AVONEX) for Multiple sclerosis.    On 04-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced PERIPHERAL SWELLING (left arm swollen / whole upper arm is swollen), SLEEP DISORDER (hard to sleep), MALAISE (not good) and CHILLS (everyday chills). On 12-May-2021, the patient experienced NASOPHARYNGITIS (I am freezing), FEELING HOT (face is warm/ hot to touch / feft arm was hot to touch), VACCINATION SITE DISCOLOURATION (still see the mark where the needle went in), ERYTHEMA (red / redness is 3-4 inches wide/ redness is 2 inches down from where the shot was given) and MYALGIA (pain under my arm/ pain in left arm). The patient was treated with PARACETAMOL (TYLENOL) on 04-May-2021 at a dose of 500mg. At the time of the report, PERIPHERAL SWELLING (left arm swollen / whole upper arm is swollen), NASOPHARYNGITIS (I am freezing), SLEEP DISORDER (hard to sleep), FEELING HOT (face is warm/ hot to touch / feft arm was hot to touch), VACCINATION SITE DISCOLOURATION (still see the mark where the needle went in), ERYTHEMA (red / redness is 3-4 inches wide/ redness is 2 inches down from where the shot was given), MALAISE (not good), CHILLS (everyday chills) and MYALGIA (pain under my arm/ pain in left arm) had not resolved.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Pruritus, Vaccination site swelling
Clinical narrative: Redness worsened, circling the arm; Red and itching increased shoulder to elbow; Swollen/injection site swelling; Shoulder to bend of elbow very itchy/itching; Arm sore; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness worsened, circling the arm), PRURITUS (Shoulder to bend of elbow very itchy/itching), PAIN IN EXTREMITY (Arm sore), ERYTHEMA (Red and itching increased shoulder to elbow) and VACCINATION SITE SWELLING (Swollen/injection site swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019b21A and 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included METFORMIN, LISINOPRIL, ATENOLOL and ATORVASTATIN for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Arm sore). On 26-Mar-2021, the patient experienced PRURITUS (Shoulder to bend of elbow very itchy/itching) and VACCINATION SITE SWELLING (Swollen/injection site swelling). On 29-Mar-2021, the patient experienced ERYTHEMA (Red and itching increased shoulder to elbow). On an unknown date, the patient experienced ERYTHEMA (Redness worsened, circling the arm). The patient was treated with CLOBETASOL for Adverse reaction, at a dose of 1 dosage form. At the time of the report, ERYTHEMA (Redness worsened, circling the arm), PRURITUS (Shoulder to bend of elbow very itchy/itching), PAIN IN EXTREMITY (Arm sore), ERYTHEMA (Red and itching increased shoulder to elbow) and VACCINATION SITE SWELLING (Swollen/injection site swelling) had resolved.            This case was linked to MOD-2021-039323 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow up report included updates on event outcome and treatment medicine.  Treatment included Clobetasol.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site dermatitis, Vaccination site pain
Clinical narrative: pink dermatitis at the injection site; soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DERMATITIS (pink dermatitis at the injection site) and VACCINATION SITE PAIN (soreness at the injection site) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C21A and 042B21A,) for COVID-19 vaccination.     The patient's past medical history included Headaches cluster (Unknown origin for 20 years). Concurrent medical conditions included Dermatitis (Prone to rashes and has very sensitive skin) and Spinal stenosis (Steroid shots every 6 months). Concomitant products included PARACETAMOL (TYLENOL) for Headache.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced VACCINATION SITE DERMATITIS (pink dermatitis at the injection site) and VACCINATION SITE PAIN (soreness at the injection site). On 12-May-2021, VACCINATION SITE PAIN (soreness at the injection site) had resolved. At the time of the report, VACCINATION SITE DERMATITIS (pink dermatitis at the injection site) was resolving. Not Provided          The patient was prescribed a steroid cream (unknown name, strength, and dose) from their health care provider for the pink dermatitis.
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Heart Palpitations; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart Palpitations) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Heart Palpitations). At the time of the report, PALPITATIONS (Heart Palpitations) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was provided.  No concomitant medication was available.  Caller says that she knows of 2 other people who had heart palpitations after receiving the Moderna Covid-19 vaccine. One of them was a young girl.  Caller does not want to provide additional details on these patients.
Sex: U
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: heard and seen that other people that had the same; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (heard and seen that other people that had the same) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (heard and seen that other people that had the same). At the time of the report, URTICARIA (heard and seen that other people that had the same) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pain in extremity, Pyrexia
Clinical narrative: Bilateral pain in both arms; Chronic pain; Headaches; High fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Bilateral pain in both arms), PAIN (Chronic pain), HEADACHE (Headaches) and PYREXIA (High fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016C21A and 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced PAIN IN EXTREMITY (Bilateral pain in both arms), PAIN (Chronic pain), HEADACHE (Headaches) and PYREXIA (High fever). On 03-May-2021, PYREXIA (High fever) had resolved. At the time of the report, PAIN IN EXTREMITY (Bilateral pain in both arms), PAIN (Chronic pain) and HEADACHE (Headaches) outcome was unknown. Not Provided          Concomitant medication list was not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-072598 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Papule, Skin warm
Clinical narrative: bumpy arm; feels warm to the touch; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAPULE (bumpy arm), SKIN WARM (feels warm to the touch) and PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAPULE (bumpy arm), SKIN WARM (feels warm to the touch) and PAIN IN EXTREMITY (sore arm). At the time of the report, PAPULE (bumpy arm), SKIN WARM (feels warm to the touch) and PAIN IN EXTREMITY (sore arm) outcome was unknown.            For the second dose of mRNA-1273, the action taken was not applicable.  No concomitant medications were reported. No treatment was reported for these events.   This case was linked to MOD-2021-058178 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up received 13-May-2021 included updated dates for both dose 1 and dose 2.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia, Pain in extremity
Clinical narrative: Pain in arm; Fatigue; Sleep excessive; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), HYPERSOMNIA (Sleep excessive) and FATIGUE (Fatigue) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 025120-2A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SALBUTAMOL (VENTOLIN [SALBUTAMOL]) for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPERSOMNIA (Sleep excessive). On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arm) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Pain in arm), HYPERSOMNIA (Sleep excessive) and FATIGUE (Fatigue) had resolved.            Consumer reported the events resolved within a few days. Treatment information not provided. Action taken for Moderna COVID-19 Vaccine was not applicable.   This case was linked to MOD-2021-025819 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nasal congestion, Pain in extremity
Clinical narrative: Stuffy nose; Headache; General body aches; Fatigue; Pain in arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), NASAL CONGESTION (Stuffy nose), HEADACHE (Headache), MYALGIA (General body aches) and FATIGUE (Fatigue) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm), HEADACHE (Headache), MYALGIA (General body aches) and FATIGUE (Fatigue). On an unknown date, the patient experienced NASAL CONGESTION (Stuffy nose). At the time of the report, PAIN IN EXTREMITY (Pain in arm), NASAL CONGESTION (Stuffy nose), HEADACHE (Headache), MYALGIA (General body aches) and FATIGUE (Fatigue) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable.  Patient was taking concomitant medications.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick). At the time of the report, ILLNESS (sick) outcome was unknown.            No treatment information provided.   This case was linked to (Patient Link).
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Vaccination complication, Vaccination site pain
Clinical narrative: patient felt exhausted; injection site felt like he'd be poked with a hot poker; severe reaction to his covid-19 vaccine; Body ache all over; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (severe reaction to his covid-19 vaccine), MYALGIA (Body ache all over), FATIGUE (patient felt exhausted) and VACCINATION SITE PAIN (injection site felt like he'd be poked with a hot poker) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (ALLEGRA D), SIMVASTATIN, DUPILUMAB, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and FEXOFENADINE HYDROCHLORIDE for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced VACCINATION COMPLICATION (severe reaction to his covid-19 vaccine), MYALGIA (Body ache all over) and VACCINATION SITE PAIN (injection site felt like he'd be poked with a hot poker). On an unknown date, the patient experienced FATIGUE (patient felt exhausted). On 06-May-2021, VACCINATION COMPLICATION (severe reaction to his covid-19 vaccine), MYALGIA (Body ache all over) and VACCINATION SITE PAIN (injection site felt like he'd be poked with a hot poker) had resolved. At the time of the report, FATIGUE (patient felt exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter. This case concerns a 68-year-old male with adverse events of Vaccine Adverse Reaction, Myalgia, Fatigue and Vaccination Site Pain with unknown days of Latency after mRNA-1273 vaccination and with co-suspect Dupilumab Subcutaneous injection for unknown indication. There is very limited information available as temporal association cannot be established (missing dates of administration of both Moderna COVID Vaccine and Dupilumab). No further information is expected at this time.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Source Document, Events added; Sender's Comments: This case concerns a 68-year-old male with adverse events of Vaccine Adverse Reaction, Myalgia, Fatigue and Vaccination Site Pain with unknown days of Latency after mRNA-1273 vaccination and with co-suspect Dupilumab Subcutaneous injection for unknown indication. There is very limited information available as temporal association cannot be established (missing dates of administration of both Moderna COVID Vaccine and Dupilumab). No further information is expected at this time.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: 102.5 Fahrenheit for the first 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (102.5 Fahrenheit for the first 24 hours) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced PYREXIA (102.5 Fahrenheit for the first 24 hours). At the time of the report, PYREXIA (102.5 Fahrenheit for the first 24 hours) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, Body temperature: 102.5 (High) fever. On 12-May-2021, Body temperature: 100 (High) fever.         Patient has not seen a primary care provider in the last four years and does not have one as well. Patient is not on any other medications. Patient would like to know how long the symptoms will last  Patient consent to document this call Patient provided local pharmacy contact information Patient granted permission for Safety to follow-up if needed
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Fatigue, Headache, Vaccination site pain
Clinical narrative: Vaccination site pain; Stomach aches; Fatigue; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain), ABDOMINAL PAIN UPPER (Stomach aches), FATIGUE (Fatigue) and HEADACHE (Headaches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain), ABDOMINAL PAIN UPPER (Stomach aches), FATIGUE (Fatigue) and HEADACHE (Headaches). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain), ABDOMINAL PAIN UPPER (Stomach aches), FATIGUE (Fatigue) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient was taking concomitant medication which were not provided or unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore; pain at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore; pain at the injection site). At the time of the report, VACCINATION SITE PAIN (Sore; pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment, medical history, lab data and concomitant medications were not reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection area still sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection area still sore) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M0A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (injection area still sore). At the time of the report, VACCINATION SITE PAIN (injection area still sore) had not resolved.            Patient stated it is fluctuated pain, worse pain at night in bed.  Concomitant medications were not reported.  Treatment information was not reported.   This case was linked to MOD-2021-123621 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow up information received contain no new information.
Sex: U
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Heart Palpitations; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart Palpitations) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Heart Palpitations). At the time of the report, PALPITATIONS (Heart Palpitations) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore; pain at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore; pain at the injection site). At the time of the report, VACCINATION SITE PAIN (Sore; pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs and treatment medications were reported.   This case was linked to MOD-2021-125065, MOD-2021-125026, MOD-2021-124992, MOD-2021-124815 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore; Pain at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore; Pain at injection site). At the time of the report, VACCINATION SITE PAIN (Sore; Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment and concomitant medication information reported.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain at injection site). At the time of the report, VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain at injection site). At the time of the report, VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No conominant medications were reported.  Treatment information was not provided.